Ceftriaxone and Entyvio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftriaxone (ceftriaxone sodium) and Entyvio (vedolizumab). Common drug interactions include haematoma among females and aphasia among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftriaxone and Entyvio. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Entyvio?

Entyvio has active ingredients of vedolizumab. It is often used in crohn's disease. eHealthMe is studying from 23,827 Entyvio users. Check the latest studies of Entyvio.

On Jul, 19, 2026

24 people who take Ceftriaxone and Entyvio together, and have interactions are studied.

Ceftriaxone and Entyvio drug interactions.

What are the common drug interactions of Ceftriaxone and Entyvio, by gender? *:

female:

Haematoma (collection of blood outside the blood vessels)
Abscess (pus)
Abscess limb (limb infection)
Colitis ulcerative (inflammation of colon with ulcer)
Diarrhoea haemorrhagic (bloody diarrhoea)
Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site oedema (swelling from excessive accumulation of watery fluid from infusion site)
Infusion site pain
Infusion site warmth

male:

Aphasia (damage to the parts of the brain that control language)
Balance disorder
Pyrexia (fever)
Suicidal ideation
Wound complication
Diabetes insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function)
Diplopia (double vision)
Encephalitis haemorrhagic (inflammation of the brain with blood extravasations)
Facial paralysis (loss of function of face muscle)
Headache (pain in head)

What are the common drug interactions of Ceftriaxone and Entyvio, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Bacterial infection
Blood bilirubin increased
Cardiac arrest
Respiratory failure (inadequate gas exchange by the respiratory system)

20-29:

Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pneumonia

30-39:

n/a

40-49:

Infusion site erythema (reddening of the skin at infusion site)
Infusion site oedema (swelling from excessive accumulation of watery fluid from infusion site)
Infusion site pain
Infusion site warmth
Tooth abscess (pus formation in tooth)
Secretion discharge
Breast abscess
Burning sensation
Erythema (redness of the skin)
Wound

50-59:

n/a

60+:

Liver disorder (liver diseases)
Polymyalgia rheumatica (pain in many muscles)
Lupus-like syndrome (a disease symptom matches with lupus an immune disease)
Wound complication

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 17 people, 70.83%
Abscess (pus): 12 people, 50.00%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 10 people, 41.67%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 10 people, 41.67%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 3 people, 12.50%
Infection: 3 people, 12.50%
Pain: 2 people, 8.33%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 2 people, 8.33%
Dementia (madness): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and Entyvio?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously